Distalmotion Secures Strategic Investment from Johnson & Johnson to Expand Robotic Surgery in ASCs

14 January 2026 | News

The investment follows Distalmotion’s $150M Series G round and supports the growth of DEXTER, a robotic system purpose-built for ambulatory surgery centers.

Subscribe to our newsletter

Monthly digest of what's new and exciting from us.

We'll never share your email with anyone else.